{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:21:37Z","timestamp":1773289297873,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"Medical University of Silesia","doi-asserted-by":"crossref","award":["NN-1-038\/10"],"award-info":[{"award-number":["NN-1-038\/10"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.pharep.2016.09.013","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T11:45:53Z","timestamp":1474026353000},"page":"45-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The effect of oral contraception on cardiometabolic risk factors in women with elevated androgen levels"],"prefix":"10.1007","volume":"69","author":[{"given":"Robert","family":"Krysiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Gilowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogus\u0142aw","family":"Okopie\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2016.09.013_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ando.2009.12.007","article-title":"French endocrine society: recommendations for investigation of hyperandrogenism","volume":"71","author":"Pugeat","year":"2010","journal-title":"Ann Endocrinol (Paris)"},{"issue":"Suppl. 1","key":"10.1016\/j.pharep.2016.09.013_bib0010","first-page":"S241","article-title":"The evaluation and treatment of androgen excess","volume":"5","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.pharep.2016.09.013_bib0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4158\/EP.7.2.120","article-title":"American Association of Clinical Endocrinologists Hyperandrogenic Disorders Task Force: American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders","volume":"7","author":"Goodman","year":"2001","journal-title":"Endocr Pract"},{"key":"10.1016\/j.pharep.2016.09.013_bib0020","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1210\/jc.2014-3196","article-title":"Approach to the patient: contraception in women with polycystic ovary syndrome","volume":"100","author":"Yildiz","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2016.09.013_bib0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40264-013-0054-6","article-title":"Drug-induced thrombosis: an update","volume":"36","author":"Ramot","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.pharep.2016.09.013_bib0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/humrep\/del407","article-title":"Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis","volume":"22","author":"Nader","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.pharep.2016.09.013_bib0035","first-page":"614","article-title":"Update on the management of polycystic ovary syndrome","volume":"58","author":"Krysiak","year":"2006","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2016.09.013_bib0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0031-1299765","article-title":"Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome","volume":"120","author":"Racho\u0144","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.pharep.2016.09.013_bib0045","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"34","author":"Randeva","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharep.2016.09.013_bib0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1530\/EJE-11-0755","article-title":"Recent advances in cardiovascular aspects of polycystic ovary syndrome","volume":"166","author":"Sathyapalan","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharep.2016.09.013_bib0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","author":"de Groot","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.pharep.2016.09.013_bib0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2265.2009.03690.x","article-title":"Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia?","volume":"73","author":"Mooij","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharep.2016.09.013_bib0065","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish Population-Based National Cohort Study","volume":"100","author":"Falhammar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2016.09.013_bib0070","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1590\/2359-3997000000119","article-title":"Cardiovascular risk factors and increased carotid intima-media thickness in young patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"59","author":"Rodrigues","year":"2015","journal-title":"Arch Endocrinol Metab"},{"issue":"12 Pt. 2","key":"10.1016\/j.pharep.2016.09.013_bib0075","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1301\/nr.2007.dec.S253-S259","article-title":"Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity","volume":"65","author":"Ridker","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1016\/j.pharep.2016.09.013_bib0080","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharep.2016.09.013_bib0085","doi-asserted-by":"crossref","first-page":"1563S","DOI":"10.1093\/ajcn\/86.5.1563S","article-title":"Homocysteine, vitamins, and vascular disease prevention","volume":"86","author":"McCully","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharep.2016.09.013_bib0090","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2165\/00003495-200363170-00005","article-title":"Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes","volume":"63","author":"Krysiak","year":"2003","journal-title":"Drugs"},{"issue":"Suppl. 1","key":"10.1016\/j.pharep.2016.09.013_bib0095","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1159\/000328015","article-title":"Microalbuminuria: marker or maker of cardiovascular disease","volume":"119","author":"Abdelhafiz","year":"2011","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.pharep.2016.09.013_bib0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.steroids.2011.10.013","article-title":"Tissue physiology and pathology of aromatase","volume":"77","author":"Stocco","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.pharep.2016.09.013_bib0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.1991.tb00940.x","article-title":"Androgen dependent stimulation of aromatase activity in genital skin fibroblasts from normals and patients with androgen insensitivity","volume":"35","author":"Stillman","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharep.2016.09.013_bib0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MED.0b013e328353732f","article-title":"Evolving utility of sex hormone-binding globulin measurements in clinical medicine","volume":"19","author":"Hammond","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.pharep.2016.09.013_bib0115","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.pharep.2016.09.013_bib0120","doi-asserted-by":"crossref","first-page":"e001388","DOI":"10.1161\/JAHA.112.001388","article-title":"High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: the three-city cohort study","volume":"1","author":"Scarabin-Carr\u00e9","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pharep.2016.09.013_bib0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.pharep.2016.09.013_bib0130","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1210\/jc.2004-1557","article-title":"Medroxyprogesterone acetate and dihydrotestosterone induce coronary hyperreactivity in intact male rhesus monkeys","volume":"90","author":"Mishra","year":"2005","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016301773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016301773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:41Z","timestamp":1752611801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.09.013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1734114016301773"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.09.013","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of oral contraception on cardiometabolic risk factors in women with elevated androgen levels","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Sp. z o.o. on behalf of Institute of Pharmacology, Polish Academy of Sciences.","name":"copyright","label":"Copyright"}]}}